Cargando…
Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials
Randomized clinical trials are considered the milestones of clinical research in oncology, and guided the development and approval of new compounds so far. In the last few years, however, molecular and genomic profiling led to a change of paradigm in therapeutic algorithms of many cancer types, with...
Autores principales: | Di Liello, Raimondo, Piccirillo, Maria Carmela, Arenare, Laura, Gargiulo, Piera, Schettino, Clorinda, Gravina, Adriano, Perrone, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618758/ https://www.ncbi.nlm.nih.gov/pubmed/34833129 http://dx.doi.org/10.3390/life11111253 |
Ejemplares similares
-
The opportunity of patient-journey studies for academic clinical research in oncology
por: Perrone, Francesco, et al.
Publicado: (2021) -
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials
por: Gargiulo, Piera, et al.
Publicado: (2021) -
A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan
por: Chiodini, Paolo, et al.
Publicado: (2020) -
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
por: Perrone, Francesco, et al.
Publicado: (2020) -
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
por: Perrone, Francesco, et al.
Publicado: (2021)